GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDL Biotech AB (XSAT:IDL) » Definitions » Price-to-Tangible-Book

IDL Biotech AB (XSAT:IDL) Price-to-Tangible-Book : 15.08 (As of May. 25, 2024)


View and export this data going back to 2004. Start your Free Trial

What is IDL Biotech AB Price-to-Tangible-Book?

As of today (2024-05-25), IDL Biotech AB's share price is kr2.88. IDL Biotech AB's Tangible Book per Share of Jun. 2021 for the quarter that ended in Jun. 2021 was kr0.19. Hence, IDL Biotech AB's Price to Tangible Book Ratio of today is 15.08.

The historical rank and industry rank for IDL Biotech AB's Price-to-Tangible-Book or its related term are showing as below:

XSAT:IDL' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.17   Med: 14.34   Max: 106
Current: 15.16

During the past 13 years, IDL Biotech AB's highest Price to Tangible Book Ratio was 106.00. The lowest was 2.17. And the median was 14.34.

XSAT:IDL's Price-to-Tangible-Book is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 2.47 vs XSAT:IDL: 15.16

A closely related ratio is called PB Ratio. As of today, IDL Biotech AB's share price is kr2.88. IDL Biotech AB's Book Value per Sharefor the quarter that ended in Jun. 2021 was kr0.30. Hence, IDL Biotech AB's P/B Ratio of today is 9.63.


IDL Biotech AB Price-to-Tangible-Book Historical Data

The historical data trend for IDL Biotech AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDL Biotech AB Price-to-Tangible-Book Chart

IDL Biotech AB Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.95 13.94 4.64 8.62 5.30

IDL Biotech AB Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.17 5.56 5.30 7.23 15.13

Competitive Comparison of IDL Biotech AB's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, IDL Biotech AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDL Biotech AB's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDL Biotech AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where IDL Biotech AB's Price-to-Tangible-Book falls into.



IDL Biotech AB Price-to-Tangible-Book Calculation

IDL Biotech AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2021 )
=2.88/0.191
=15.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


IDL Biotech AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of IDL Biotech AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


IDL Biotech AB (XSAT:IDL) Business Description

Traded in Other Exchanges
N/A
Address
Karlsbodavagen 39, Stockholm, SWE
IDL Biotech AB develops, produces and markets In Vitro Diagnostic tests for the health care sector. It offers in vitro diagnostic tests within the clinical areas of oncology and bacteriology. The company's trademark products includes TUBEX, TPS, UBC, MonoTotal and TPAcyk.

IDL Biotech AB (XSAT:IDL) Headlines

No Headlines